Stay updated on Seribantumab in NRG1 Gene Fusion Clinical Trial
Sign up to get notified when there's something new on the Seribantumab in NRG1 Gene Fusion Clinical Trial page.

Latest updates to the Seribantumab in NRG1 Gene Fusion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry (v3.3.3) was added to the history page. The HHS Vulnerability Disclosure link and the earlier revision (v3.3.2) were removed from the footer.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page header/footer, reflecting an administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site revision label was updated from v3.2.0 to v3.3.1 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding operation status notice banner on the page was removed. This change does not alter the core trial information or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check58 days agoChange DetectedThe new screenshot shows an updated Record History with an additional version entry, but no visible changes to core trial information (status, eligibility, or results). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference10%

Stay in the know with updates to Seribantumab in NRG1 Gene Fusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seribantumab in NRG1 Gene Fusion Clinical Trial page.